A treatment for advanced hepatocellular carcinoma, the most common type of primary liver cancer, is to be covered by National Health Insurance (NHI) from Tuesday next week, the National Health Insurance Administration said yesterday.
Medical Review and Pharmaceutical Benefits Division head Huang Yu-wen (黃育文) said the policy covering atezolizumab plus bevacizumab combination therapy is expected to benefit 2,072 people with advanced liver cancer, allowing them to save about NT$3 million (US$95,688) in annual medical expenses.
In 2019, the NHI included three types of immune checkpoint inhibitors — nivolumab, pembrolizumab and atezolizumab — for the treatment of eight types of cancers, including liver cancer.
Photo: CNA
However, immunotherapy for liver cancer was removed from the list the following year, as NHI funding is limited and studies at the time suggested that its efficacy was not significantly better than targeted therapy, Huang said.
As more studies were conducted and clinical data collected, some countries approved the combination of atezolizumab, an immunotherapy drug, with bevacizumab, a targeted therapy drug, as the standard of care for first-line systemic therapy for advanced hepatocellular carcinoma, she said.
A study published last year showed that the median overall survival was 5.8 months longer in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab than those treated with sorafenib, a targeted therapy drug, she said.
Huang said that as the combination therapy has been adopted as the standard first-line therapy for treating advanced hepatocellular carcinoma in clinical treatment guidelines, and considering the clinical evidence and benefits to people with liver cancer, the Pharmaceutical Benefit and Reimbursement Scheme Joint Committee on June 15 approved the inclusion of the treatment in the NHI system.
Taiwanese were praised for their composure after a video filmed by Taiwanese tourists capturing the moment a magnitude 7.5 earthquake struck Japan’s Aomori Prefecture went viral on social media. The video shows a hotel room shaking violently amid Monday’s quake, with objects falling to the ground. Two Taiwanese began filming with their mobile phones, while two others held the sides of a TV to prevent it from falling. When the shaking stopped, the pair calmly took down the TV and laid it flat on a tatami mat, the video shows. The video also captured the group talking about the safety of their companions bathing
US climber Alex Honnold is to attempt to scale Taipei 101 without a rope and harness in a live Netflix special on Jan. 24, the streaming platform announced on Wednesday. Accounting for the time difference, the two-hour broadcast of Honnold’s climb, called Skyscraper Live, is to air on Jan. 23 in the US, Netflix said in a statement. Honnold, 40, was the first person ever to free solo climb the 900m El Capitan rock formation in Yosemite National Park — a feat that was recorded and later made into the 2018 documentary film Free Solo. Netflix previewed Skyscraper Live in October, after videos
Starting on Jan. 1, YouBike riders must have insurance to use the service, and a six-month trial of NT$5 coupons under certain conditions would be implemented to balance bike shortages, a joint statement from transportation departments across Taipei, New Taipei City and Taoyuan announced yesterday. The rental bike system operator said that coupons would be offered to riders to rent bikes from full stations, for riders who take out an electric-assisted bike from a full station, and for riders who return a bike to an empty station. All riders with YouBike accounts are automatically eligible for the program, and each membership account
A classified Pentagon-produced, multiyear assessment — the Overmatch brief — highlighted unreported Chinese capabilities to destroy US military assets and identified US supply chain choke points, painting a disturbing picture of waning US military might, a New York Times editorial published on Monday said. US Secretary of Defense Pete Hegseth’s comments in November last year that “we lose every time” in Pentagon-conducted war games pitting the US against China further highlighted the uncertainty about the US’ capability to intervene in the event of a Chinese invasion of Taiwan. “It shows the Pentagon’s overreliance on expensive, vulnerable weapons as adversaries field cheap, technologically
RSS